#United States #AI Solutions #Marlborough #digital health #Persivia

Persivia's Successful Recapitalization: Paving the Way for Future Growth

On April 29, 2025, Persivia, an innovator in AI-driven digital health solutions, announced a significant milestone in its journey with the completion of a $107 million recapitalization. This financial boost, supported by Aldrich Capital Partners, a prominent growth equity firm focusing on high-potential healthcare and technology companies, marks the beginning of an exciting new era for Persivia.

Enhancing Innovation and Nationwide Reach

The infusion of capital aims to accelerate Persivia's ambitious expansion plans. Over the next year, the company is poised to significantly grow its sales force while rolling out cutting-edge AI-powered solutions. These advancements are specifically designed to enhance operational efficiency and improve patient management for healthcare organizations across the nation.

Dr. Mansoor Khan, CEO of Persivia, expressed his enthusiasm, stating, "This partnership is about more than just capital. It represents the launch of a national growth strategy and our commitment to making our platform the go-to choice for healthcare organizations seeking clean, actionable data and AI-driven tools that facilitate value-based care."

Dr. Fauzia Khan, COO of Persivia, highlighted the team's dedication and success in utilizing AI to develop an industry-leading digital health platform. She emphasized that the company has consistently aimed for excellence across all facets of operation—from product management and engineering to support and account management. The positive client feedback illustrated by an impressive Net Promoter Score (NPS) of 83 was also a testament to the company's success.

A Transformative Approach to Healthcare Data

Persivia's platform has gained the trust of leading health systems and payers as it simplifies workflows, reduces costs, and enhances patient outcomes significantly. What sets it apart is its ability to offer a unified AI-powered solution that provides clean, governed data across various users and applications. This includes applications in value-based care, population health, quality improvement, and beyond.

Mirza Baig, Managing Partner at Aldrich Capital Partners, shared his excitement about the partnership, noting that their objective is to help Persivia accelerate growth through targeted acquisitions and strategic partnerships that will expand the company's capabilities and market presence.

In addition to the financial backing and strategic insight from Aldrich Capital Partners, Persivia's vision has garnered interest from notable figures in the healthcare industry. Ron Zwanziger, the founder of Alere Inc. and Electra DX, who is also a key investor in Persivia, expressed his satisfaction in seeing the fruition of their long-term goal of enhancing healthcare outcomes through innovative solutions.

Conclusion

The successful recapitalization positions Persivia for not just a promising future, but also a transformational role in reshaping how healthcare organizations operate. With a commitment to continuous improvement and innovation, Persivia is paving the way for smarter healthcare solutions that benefit providers and patients alike. Headquartered in Marlborough, MA, Persivia currently supports over 200 hospitals and more than 12,000 clinicians nationwide, proving its capability and reliability in the healthcare technology landscape. For further information about Persivia and its offerings, visit www.persivia.com.